BNY Mellon International Equity C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
BNY Mellon International Equity Fund Class C NIECX
- NAV / 1-Day Return 17.79 / −1.11 %
- Total Assets 329.3M
-
Adj. Expense Ratio
1.770%
- Expense Ratio 1.790%
- Distribution Fee Level Below Average
- Share Class Type Level Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.52%
- Turnover 230%
USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:11 AM GMT+0
Morningstar’s Analysis NIECX
Will NIECX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
ASML Holding NV | 4.45 | 15M | Technology |
Nestle SA | 2.44 | 8M | Consumer Defensive |
Banco Santander SA | 2.44 | 8M | Financial Services |
AstraZeneca PLC | 2.29 | 7M | Healthcare |
Sumitomo Mitsui Financial Group Inc | 2.24 | 7M | Financial Services |
ING Groep NV | 2.12 | 7M | Financial Services |
BNP Paribas Act. Cat.A | 1.98 | 6M | Financial Services |
Novartis AG Registered Shares | 1.92 | 6M | Healthcare |
Schneider Electric SE | 1.86 | 6M | Industrials |
GSK PLC | 1.86 | 6M | Healthcare |